Cargando…

Long-term albumin infusion in decompensated cirrhosis: A review of current literature

Decompensated cirrhosis is characterized by chronic inflammation and severe portal hypertension leading to systemic circulatory dysfunction. Albumin infusion has been widely used in decompensated cirrhosis in patients with spontaneous bacterial peritonitis, large-volume paracentesis and hepatorenal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Yu Jun, Kumar, Rahul, Chua, Yu Jing Jonathan, Ang, Tiing Leong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080546/ https://www.ncbi.nlm.nih.gov/pubmed/33959225 http://dx.doi.org/10.4254/wjh.v13.i4.421

Ejemplares similares

Albumin administration in patients with cirrhosis: Current role and novel perspectives
por: de Mattos, Ângelo Zambam, et al.
Publicado: (2022)

Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2023)

Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis
por: China, Louise, et al.
Publicado: (2022)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Outpatient albumin infusions reduce hospitalizations and improve outcomes in decompensated cirrhosis: A real‐world cohort study
por: Hannah, Nicholas, et al.
Publicado: (2023)

Prognostic value of neutrophil count to albumin ratio in patients with decompensated cirrhosis
por: Yao, Junjie, et al.
Publicado: (2023)

Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice
por: Ferrarese, Alberto, et al.
Publicado: (2021)

Long-term administration of Tolvaptan to patients with decompensated cirrhosis
por: Kanayama, Kengo, et al.
Publicado: (2020)

Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
por: Grüngreiff, Kurt, et al.
Publicado: (2021)

Pulmonary complications of portal hypertension: The overlooked decompensation
por: Craciun, Rares, et al.
Publicado: (2022)

Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2018)

Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
por: Moran, Segundo, et al.
Publicado: (2021)

Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
por: Giordano, Guido, et al.
Publicado: (2017)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
por: Runken, M. Chris, et al.
Publicado: (2019)

Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
por: Baldassarre, Maurizio, et al.
Publicado: (2021)

Prognostic value of albumin‐related ratios in HBV‐associated decompensated cirrhosis
por: Zhang, Tan, et al.
Publicado: (2022)

Effective albumin – A novel paradigm in the management of decompensated liver cirrhosis
por: Bernardi, Mauro
Publicado: (2023)

Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review
por: Shizuma, Toru
Publicado: (2018)

COVID-19 vaccination and myocarditis: A review of current literature
por: Dhaduk, Kartik, et al.
Publicado: (2022)

Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
por: Runken, M. Chris, et al.
Publicado: (2020)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
por: Seen, Tasur Kumar, et al.
Publicado: (2021)

Use of albumin infusion for cirrhosis-related complications: An international position statement
por: Bai, Zhaohui, et al.
Publicado: (2023)

Breast reconstruction: Review of current autologous and implant-based techniques and long-term oncologic outcome
por: Malekpour, Mahdi, et al.
Publicado: (2023)

Muscular abnormalities in liver cirrhosis
por: Hari, Andrej
Publicado: (2021)

Anemia in cirrhosis: An underestimated entity
por: Manrai, Manish, et al.
Publicado: (2022)

Implication of the intestinal microbiome in complications of cirrhosis
por: Bhat, Mamatha, et al.
Publicado: (2016)

Neutrophil count to albumin ratio as a prognostic indicator for HBV‐associated decompensated cirrhosis
por: Han, Zhong, et al.
Publicado: (2021)

Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
por: Bai, Zhaohui, et al.
Publicado: (2021)

Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2022)

Nutritional evaluation in cirrhosis: Emphasis on the phase angle
por: Fernandes, Sabrina Alves, et al.
Publicado: (2016)

Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018)

Hepatocyte transplantation: Consider infusion before incision
por: Heath, Ryan D, et al.
Publicado: (2017)

Management of refractory ascites in cirrhosis: Are we out of date?
por: Annamalai, Alagappan, et al.
Publicado: (2016)

Spectrum of esophageal motility disorders in patients with liver cirrhosis
por: Khalaf, Mohamed, et al.
Publicado: (2020)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Impact of multidrug resistance on the management of bacterial infections in cirrhosis
por: Terra, Carlos, et al.
Publicado: (2023)

Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
por: Zhao, Hong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_56s9bg10n2r1bfov4m3llhco58